Intraocular Lens Calculation Using Artificial Intelligence
NCT ID: NCT07202767
Last Updated: 2025-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
170 participants
OBSERVATIONAL
2025-11-01
2028-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
By then combining these two approaches with artificial intelligence, the aim is to develop a new approach to effectively incorporate the LD in IOL power calculation and improve patient's outcome in the long run.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
1000 Eyes Lens Biometry Study: Artificial Intelligence for Intraocular Lens Power Calculation
NCT05779319
Intraocular Lens Power Calculation Using Pre- and Intra-operative Measurements
NCT02513134
Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation
NCT07146737
Intra-operative Measurements to Predict the Position of the Intraocular Lens Post-operatively
NCT01867541
Positional Stability and Refractive Behaviour After Implantation of an IOL After Cataract Surgery
NCT06069752
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Significant progress has been made in calculation concepts over the past 20 years, including the introduction of regression, vergence and ray tracing. More recently, approaches incorporating artificial intelligence have emerged.
All these formulae are based on the biometric data of the eye. This includes parameters such as axial eye length, corneal curvature, central corneal thickness, anterior chamber depth and the refractive indices of the eye's optical segments. By including all these variables, modern formulas aim to deliver the best possible postoperative outcomes.
One variable that has not been included in the calculation thus far is the diameter of the natural lens. Large parts of the lens are covered by the iris. Even with medically dilated pupils the peripheral parts cannot be visualized, and subsequently not adequately reproduced using established imaging methods. This has made implementation in IOL power calculation difficult.
In everyday clinical practice, however, anterior segment OCT imaging devices are equipped with features that allow for an estimation of lens diameter. This is achieved by extrapolating the anterior and posterior curvature of the natural lens, which unfortunately makes this approach prone to error. Other imaging techniques, such as magnetic resonance imaging, are impractical in routine clinical practice due to time and cost considerations. However, they could be highly beneficial for future predictive approaches of the lens diameter The aim of this study is to develop a model for incorporating the lens diameter into IOL calculation. This will be achieved by using different imaging technologies to determine the actual lens diameter. The diameter will then be predicted using available biometric variables.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study Cohort with MRI
Patients who are included in this study who additionally receive a cerebral MRI
Swept-Source Anterior Segment OCT
Device: Swept-Source Anterior Segment OCT The CASIA-2 (Tomey, Japan) is a high-resolution swept-source anterior segment OCT with CE certification. The device allows for incomplete visualization of the lens, including the anterior and posterior lens curvature.
Device: AS-OCT + Placido disc corneal topography The MS-39 (CSO, Italy) is a non-invasive device that combines Placido topography with OCT-based anterior segment tomography.
Device: Wave-front abberomtery The OSIRIS aberrometer is a standard tool for examining corneal aberration and measuring the ocular wavefront.
Device: Swept-Source OCT The IOLMaster 700 (Carl Zeiss Meditec, Germany) is a standard swept-source OCT used for eye examinations.
Device: AS-OCT The ANTERION (Heidelberg Engineering, Germany) is an anterior segment swept-source OCT.
Diagnostic Test: Refraction Subjective Refraction evaluation using the cross-cylinder method
Study cohort without MRI
Study cohort who doesn't receive an MRI
Swept-Source Anterior Segment OCT
Device: Swept-Source Anterior Segment OCT The CASIA-2 (Tomey, Japan) is a high-resolution swept-source anterior segment OCT with CE certification. The device allows for incomplete visualization of the lens, including the anterior and posterior lens curvature.
Device: AS-OCT + Placido disc corneal topography The MS-39 (CSO, Italy) is a non-invasive device that combines Placido topography with OCT-based anterior segment tomography.
Device: Wave-front abberomtery The OSIRIS aberrometer is a standard tool for examining corneal aberration and measuring the ocular wavefront.
Device: Swept-Source OCT The IOLMaster 700 (Carl Zeiss Meditec, Germany) is a standard swept-source OCT used for eye examinations.
Device: AS-OCT The ANTERION (Heidelberg Engineering, Germany) is an anterior segment swept-source OCT.
Diagnostic Test: Refraction Subjective Refraction evaluation using the cross-cylinder method
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Swept-Source Anterior Segment OCT
Device: Swept-Source Anterior Segment OCT The CASIA-2 (Tomey, Japan) is a high-resolution swept-source anterior segment OCT with CE certification. The device allows for incomplete visualization of the lens, including the anterior and posterior lens curvature.
Device: AS-OCT + Placido disc corneal topography The MS-39 (CSO, Italy) is a non-invasive device that combines Placido topography with OCT-based anterior segment tomography.
Device: Wave-front abberomtery The OSIRIS aberrometer is a standard tool for examining corneal aberration and measuring the ocular wavefront.
Device: Swept-Source OCT The IOLMaster 700 (Carl Zeiss Meditec, Germany) is a standard swept-source OCT used for eye examinations.
Device: AS-OCT The ANTERION (Heidelberg Engineering, Germany) is an anterior segment swept-source OCT.
Diagnostic Test: Refraction Subjective Refraction evaluation using the cross-cylinder method
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* planned uncomplicated bilateral cataract surgery
* availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits
* ability to consent to the participation in the study
* signed informed consent
Exclusion Criteria
* combined surgery (cataract plus glaucoma/vitreoretinal/corneal surgery)
* PEX, previous ocular surgery, severe trauma or any pathology that could lead to an unstable capsular bag
* glaucoma or any other retinal disease that may affect visual acuity significantly
* pregnancy
* pre-operative visual acuity below 0.1 Snellen decimal (1.0 Log MAR)
* pupil diameter \<4mm
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johannes Kepler University of Linz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nino Hirnschall, MD PhD
Role: PRINCIPAL_INVESTIGATOR
JKU Linz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kepler University Clinic, Linz
Linz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KUK-Ophthalmology-015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.